|Day Low/High||37.63 / 38.19|
|52 Wk Low/High||29.93 / 40.41|
We used some of the proceeds to boost our stake in Jive Software this week. In addition, we initiated a position in drug-delivery system developer, Antares Pharma.
We used a price decline to add to our position in TherapeuticsMD this week.
We’d look to purchase Builders FirstSource, Jive Software and TherapeuticsMD on near-term declines.
Synovus Financial Corp. (NYSE: SNV) announced the appointment of F.
We would consider adding to our position at around $38.
It largely depends on your mindset, but also on how your trades are set up.
Synovus Financial Corp. (NYSE: SNV) today reported financial results for the quarter and year ended December 31, 2016.
We would consider adding to TherapeuticsMD on the next market decline and booking profits in ON Semiconductor into a rally.
We didn't trade in the model portfolio this week, but several of our holdings made big moves so far this year.
The Board of Directors of Synovus Financial Corp. (NYSE: SNV) has declared a dividend of $0.
Synovus Financial Corp. (NYSE: SNV) will announce fourth quarter 2016 results on Tuesday, January 17, 2017.
We closed out a number of holdings for big gains in 2016, including McDermott, Cott and CECO Environmental.
We didn't make any trades this week but are keeping 40% of the portfolio in cash to add names as opportunities arise.
We bought more TherapeuticsMD and Yamana Gold using proceeds from the sale of some Orasure shares.
Shareholders of CalAtlantic, Huntington Bancshsares and Synovus Financial all will qualify for dividends this week.
We bought shares of TherapeuticsMD but still have a large portion of the portfolio in cash.
Our trading discipline dictates that we not be greedy when we’re sitting on a sizable gain.
We booked some profits in Huntington Bancshares and SLM this week and cut our rating on SLM from One to Two.
The Board of Directors of Synovus Financial Corp. (NYSE: SNV) has declared a quarterly dividend of $0.
We booked some profits in Synovus Financial and used part of the proceeds to buy more Yamana Gold.
We'll sell some SNV on strength and roll that into AUY on weakness.
We sold the rest of our Datalink holdings and will use the proceeds to add a name to our portfolio.
Synovus Financial Corp. (NYSE:SNV) Chairman and CEO Kessel Stelling will present at the Bank of America Merrill Lynch Future of Financials 2016 Conference in New York on Wednesday, November 16, 2016, at 11:40 a.
We used this week's declines to add to our position in Jive Software and Sonus Networks.
We used this week's declines to add to our positions in Teligent and Sonus Networks.
Synovus (SNV) reported earnings that topped analysts' projections for the 2016 third quarter.
Synovus Financial Corp. (NYSE: SNV) today reported financial results for the quarter ended September 30, 2016.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.